Atherosclerosis and Cerebral Ischemic Attacks - Intakes of Cerebrography With Xe-133 Inhaled and Platelet Tests in the Diagnosis, Clinical and Therapeutic Monitoring - the Preventive Role of Dipyridamole

Solvay, H.;Kahn, M.;Selosse, P.;Carlier, J.;Fenollar, J.;et.al.
(1984) Angiology — Vol. 35, n° 11, p. 709-718 (1984)

Files

No attached file found for this publication.

Details

Authors
  • Solvay, H.
    Author
  • Kahn, M.
    Author
  • Selosse, P.
    Author
  • Carlier, J.
    Author
  • Delwiche, Jean-PierreUCLouvain
    Author
  • Fenollar, J.
    Author
Show more
Abstract
(en) A study of patients to develop the significance of the role of the blood plate lets in the recurrence of transient cerebral ischemic attacks in patients with cerebral atheromatous, develop the effectiveness of dipyridamole in the prophy lactic therapeutic regimen. In the group treated with dipyridamole, a 76.3% clinical improvement was recorded (mean increases of 11.2 ml/min. and 11.4 ml/min. of the cerebral hemispheric flows), 15.8% of cases stabilized (mean increases of 1.7 ml/min. and 1.2 ml/min.) and 7.9% failures (mean decreases of 10.4 ml/min. and 14.3 ml/min.) of these same flows. The cerebrography with xenon 133 inhaled as well as the platelet tests used, constitute unfailing means of diagnosing and monitoring the clinical development.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Solvay, H., Kahn, M., Selosse, P., Carlier, J., Cloarec, M., Delwiche, J.-P., & Fenollar, J. (1984). Atherosclerosis and Cerebral Ischemic Attacks - Intakes of Cerebrography With Xe-133 Inhaled and Platelet Tests in the Diagnosis, Clinical and Therapeutic Monitoring - the Preventive Role of Dipyridamole. Angiology, 35(11), 709-718. https://doi.org/10.1177/000331978403501104 (Original work published 1984)